All Healthcare articles – Page 8
-
White papersSo How About that Vaccine?
How close is a vaccine? Who will make money? What’s the impact to other health care sectors? Alexandra Hillier, Ben Eaton & Akan Oton join the Investment Institute and discuss public and private markets on what keeps us up at night (and home much of the day).
-
White papersTakeda Pharmaceutical - UK Institutional
Takeda Pharmaceutical has significantly improved the transparency and accountability of its executive remuneration, aligning itself more closely to global peers.
-
White papersCorona hasn’t changed the climate crisis
The corona crisis, the US elections, trade wars… the climate problem remains. And also the need for an investment strategy that specifically responds to climate change. If anything, the health crisis has created additional opportunities to outperform the market this year due to stimulus for green sectors, argue Ulrik Fugmann and Edward Lees, who head the Environmental Strategies Group at BNP Paribas Asset Management.
-
White papersThe coronavirus and the race for a vaccine
Across the globe, scientists are hunting for an effective vaccine that will end Covid-19. In the sixth article in our pandemic series, Katie Frame looks at the response from the pharmaceutical sector and how we engage on this issue.
-
White papersWith a focus on liquidity, US dollar, sterling money markets have potential yet
Central banks provided economies with ample cash as the economic effects of the COVID-19 health crisis bit, driving down interest rates – and absolute returns – in the process, but as Philippe Renaudin, head of global money markets, tells senior investment strategist Daniel Morris in this interview, careful selection and diversification mean potential for competitive returns remains in money markets.
-
White papersIt’s Not the Beginning of the End; It’s the End of the Beginning
As investors look past the pandemic, the weak cycle coming into view means the best returns depend on identifying secular change.
-
White papersMarket Perspectives - Covid paralysis recedes as political risk rises
After a buoyant August for risk assets, the rally is likely to flatten out. Rising new infections into the autumn, a levelling recovery pace and diverse political risks (US politics, Brexit, geopolitics) will keep a lid on risk sentiment.
-
White papersPockets of growth in a “silver” economy
For the first time in history, the Earth hosts more people aged over 60 than under five. Today, people in many countries can expect to live into their sixties or longer. Older people can pursue new activities in education, work or their hobbies. Yet having the freedom to do so depends on two things – health and finance.
-
White papersLife after Covid: the LDI view
The fast spreading of the new Coronavirus disease (Covid- 19) has become the biggest global challenge in decades, with more than 10 million (recorded) infections and a death toll exceeding 500k by mid-2020. Transmission by asymptomatic people is still debated, but may be a factor facilitating unconscious spreading, and making containment difficult.
-
White papersAntimicrobial resistance and the challenge for pharmaceutical companies
A lack of research and development into new antibiotic classes compounds the serious threat that antimicrobial resistance poses to public health. In the fifth article in our pandemic series, Kimberley Lewis explores the role of pharmaceutical companies and how we engage on this key topic.
-
White papersThe digital divide, fracturing society
Without connectivity and digital skills large sections of society are at risk of being marginalised in the new economy. Senior investment strategist Daniel Morris talks to Anu Rames, technology and healthcare analyst for our Sustainability Centre, about the digital divide and the implications for investors.
-
White papersA Promising Update On The Vaccine We Are All Waiting For
We believe there is good reason to be optimistic. The global effort to develop a vaccine for COVID-19 has progressed at an incredible speed and is breathtaking when put in the context of vaccine development, which typically takes around a decade.
-
White papersShaping a new world
We are in the midst of a health crisis that is causing huge disruption within our society: it is weakening companies, upsetting our daily lives, af- fecting the poorest, deepening inequalities and jeopardising the future of many young people. Today, it is not simply urgent to support the economic recovery, it has also become imperative to speed up the environmental and inclusive transition.
-
White papersThe hottest equity themes in a post-pandemic world
It is already clear that the 2020 pandemic has given rise to a cycle of low growth and high debt. In this setting, value added will likely be generated more effectively by actively picking equity investments and doing so with a high dose of conviction. We believe that to find the incongruities in performance between the top companies and the others, investors need to be highly selective.
-
White papersMarket weekly – Healthcare, an investment theme for the coming decade
Both US and global healthcare stocks have outperformed their respective broader markets during the coronavirus pandemic. This is just the start of a long-term trend, says Jon Stephenson, senior portfolio manager for US equities and specialist for healthcare innovators in our Boston office. In this week’s podcast Daniel Morris, senior market strategist, discusses with Jon why healthcare stands out as the sector that may become the investment theme for this decade.
-
White papersG4S case study
G4S has significantly improved its health and safety standards and performance. It has come a long way to achieve this since EOS began engaging with the company in 2009 on health and safety management.
-
White papersMegatrends: After the Great Lockdown – new business realities and the implications for investors
New Business Realities and the Implications for Investors
-
Asset Manager NewsPATRIZIA launches new EUR 700m healthcare fund
PATRIZIA Immobilien AG, the global partner for pan-European real estate investment, has launched its third healthcare fund with a focus on care properties in Germany.
-
White papersThe Medical Real Estate Boom
In 2018, health care became the biggest employer in the U.S., now about 12% of the workforce, largely driven by population demographics. Millennials are the largest generation in history and over one-third of Americans are now over age 50.
-
Asset Manager NewsOrchard Street acquires premier London gym
Orchard Street Investment Management (‘Orchard Street’), the specialist commercial property investment manager, today announces the freehold acquisition of a Virgin Active gym, located on Smugglers Way, Wandsworth, London for £12.95 million. The transaction, made on behalf of St James’s Place Property Unit Trust from TH Real Estate, reflects a net initial yield of 5.0%.
